“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day has said.
Remdesivir, a drug developed by Gilead Sciences, has grabbed attention as one of the most promising treatments for Covid-19, the respiratory disease caused by the novel coronavirus, which has killed more than 250,000 people.
Experimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, US government and company officials say.
European stock markets dropped as EU leaders are not able to agree on a stimulus for the bloc's economy, while shares in the rest of the world dropped after disappointing news surrounding a potential coronavirus treatment.
The experimental drug, which previously failed in trials against Ebola, was said not to show a difference in time to clinical improvement in a draft summary of findings that briefly went online on the WHO's website.
Subscribe to our Youtube channel for all latest in-depth, on the ground reporting from around the world.
Copyright © 2020 TRT World.